ReShape Lifesciences Inc.

NasdaqCM:RSLS

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🩺 Medical Instruments

💻 Telehealth

Location

United States

Market Cap

USD 9.35 M

Share Price

USD 15.68

Avg Daily Volume

913,035

Change (1 day)

22.50%

Change (1 year)

51.94%

Change (YTD)

251.57%

ReShape Lifesciences Inc. EBITDA Margin for the year ending December 31, 2024: -83.29%

ReShape Lifesciences Inc. EBITDA Margin is -83.29% for the year ending December 31, 2024, a -50.10% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

ReShape Lifesciences Inc. EBITDA Margin for the year ending December 31, 2023 was -166.92%, a -24.73% change year over year.
ReShape Lifesciences Inc. EBITDA Margin for the year ending December 31, 2022 was -221.75%, a -50.25% change year over year.
ReShape Lifesciences Inc. EBITDA Margin for the year ending December 31, 2021 was -445.71%, a 178.32% change year over year.
ReShape Lifesciences Inc. EBITDA Margin for the year ending December 31, 2020 was -160.15%, a 40.30% change year over year.